On December 22, 2020, the Department of Justice’s (“DOJ”) Civil Division, Consumer Protection Branch, and five U.S. Attorneys’ Offices announced a groundbreaking civil enforcement action against Walmart Inc. (“Walmart”). The 160-page complaint alleges that the world’s largest company (by revenue) and the operator of over 5,000 in-store pharmacies contributed to the national opioid crisis by
Latest Post
More Posts
Despite Promises to the Contrary, Enforcement Against Nursing Homes Has Fallen Short—When It’s Been Needed the Most
Telemedicine Fraud is the New Opioids: DOJ’s First Health Care Fraud Takedown During COVID-19
Lessons Learned from the R. Kelly Legal Saga for White Collar Defense – Part 2
Lessons Learned from the R. Kelly Legal Saga for White Collar Defense – Part 1
Criminal Enforcement Risks for Nursing Homes During the COVID-19 Pandemic
Did Thousands of Doctors and Pharmacists Prescribe Dangerous and Ineffective Medication to Treat COVID-19?
Subscribe: Subscribe via RSS
Blogs
Firm/Org